Abstract
Recent data have advanced our ability to detect, survey, and manage patients with colonic neoplasia. Current studies and consensus statements increasingly support the role of colonoscopic screening over less invasive testing such as FOBT or FS for appropriately selected individuals. There are many issues, however, that remain unresolved. What is the appropriate surveillance of an individual with a single family member who had colon cancer at an early age? How should family members of suspected HNPCC kindreds be managed? There has yet to be a prospective cohort validation of the Bethesda criteria in directing clinical practice, with the endpoint of mortality reduction. Questions regarding prophylaxis with dietary supplements and medications are exciting areas that are currently under study. As newer technologies become clinically available for molecular diagnostics and screening, and virtual colonoscopy with computed tomography and magnetic resonance disseminates, there will undoubtedly be new questions to be answered regarding their ability to aid in the detection and management of colon cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 565-586 |
| Number of pages | 22 |
| Journal | Gastroenterology Clinics of North America |
| Volume | 31 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2002 |
Keywords
- Chemoprevention
- Colorectal Neoplasms/diagnosis
- Diet
- Humans
- Mass Screening/methods
- Patient Selection
- Risk Assessment
